Xos, Inc.

XOS
Country: United StatesPrice: $1.71Market Cap: $25.7M

Investment snapshot

12%positive consensus
Scored 1d ago

Positive

2

BUY / PASS

Neutral / negative

4 / 10

NEUTRAL / FAIL

Median fair value

$12.71

+643.6% vs price

Models with upside

2 / 17

Positive margin of safety

Strongest signal

XOS undervalued: all 2 models price fair value above $1.71 (median $12.71)

Key risk

15 of 16 flag XOS's profitability — Graham, Buffett, Lynch +12 more

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2957 (Top 95.5%)NEUTRALFAILPASSNEUTRALFAILFAILPASSNEUTRALFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/A+80.0%N/AN/AN/A+89.9%N/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-30

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Where It Passes

  • Valuation models100% pass✓ 2▾

    XOS undervalued: all 2 models price fair value above $1.71 (median $12.71)

    Munger fair value$8.57
    ✓Munger+80.0% margin vs $1.71
    Ackman fair value$16.86
    ✓Ackman+89.9% margin vs $1.71

Where It Falls Short

  • Profitability6% pass✓ 5✗ 30▾

    15 of 16 flag XOS's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)1/7 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)1/7 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-95.6%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-71.9% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)N/A (negative mean EPS)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-145.4%
    ✗Lynch> 15%
    EBIT / Enterprise Value-134.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-134.1%, ROC=-200.5%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-41.95%
    ✗PiotroskiROA > 0
    ROA Change YoY-51.01% -> -41.95% (delta: +9.06%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=8.89%, ROA=-41.95%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY7.1% -> 5.9%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-109.1%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-145.4%
    ✗Dreman> 12%
    Margin of SafetyP/B=0.8x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity-141.9% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency1/6 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-111.6%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-145.4%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-145.9% (2023) -> -71.9% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin -2.9% -> 5.9%, operating margin -145.9% -> -71.9%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-113.43%; #5452/6340 (top 86.0%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+6.05%; #3049/3702 (top 82.4%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-145.36%; #4770/5226 (top 91.3%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.2942; #4588/5884 (top 78.0%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years1/6 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Growth13% pass✓ 3✗ 10▾

    7 of 8 flag XOS's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: -13.4% vs Rev: -48.8%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$-0.23 (2020) -> $-2.71 (2025)
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency1/6 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth22.4%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency3/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin -2.9% -> 5.9%, operating margin -145.9% -> -71.9%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR77.1%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Valuation15% pass✓ 9✗ 19▾

    11 of 13 flag XOS's valuation — Graham, Lynch, Greenblatt +8 more

    Price / Book Value per Share0.8x
    ✓Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio0.8x
    ✓Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-134.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-134.1%, ROC=-200.5%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)3.6x
    ✓Dreman< 8x
    Valuation Reasonableness
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=20.8%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=0.8x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share3.6x
    ✓Ackman<= 25
    Price vs. Trailing Low105% of trailing low ($1.63)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-113.43%; #5452/6340 (top 86.0%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.7803; #1980/6449 (top 30.7%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share0.84x
    ✓SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+1.0381; #1739/5247 (top 33.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-17.95%; #3477/4519 (top 76.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-25.00%; #4206/6202 (top 67.8%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Verdicts15% pass✓ 2✗ 11▾

    Split decision: 10 FAIL · 4 NEUTRAL · 2 PASS

    Overall verdict
    ✗GrahamFAIL (1/9)✗BuffettFAIL (1/9)✗LynchFAIL (0/7)✗GreenblattRank #2957•PiotroskiNEUTRAL (F-Score 6)✗DremanFAIL (4/11)✓MungerPASS (2/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (1/6)✗MarksFAIL (1/5)✓AckmanPASS (5/9)•TempletonNEUTRAL (5/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #1879/2370 (Top 79.3%))✗NeffFAIL (1/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency25% pass✓ 3✗ 8▾

    6 of 8 flag XOS's efficiency — Graham, Buffett, Greenblatt +3 more

    Current Ratio1.74
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-95.9%
    ✗Buffett> 10%
    ROIC - WACC-105.9%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-200.5%
    ✗Greenblatt> 25%
    Current Ratio Change YoY1.76 -> 2.11
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.57x -> 0.76x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities1.74
    ✓Dreman> 1.5
    Return on Invested Capital-86.7%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-77.6%; FY2024: ROIC=-103.9%; FY2025: ROIC=-72.1%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest -72.1%)
    ✗SleepROIC > 12% in a majority of years
  • Cash Flow30% pass✓ 5✗ 7▾

    7 of 10 flag XOS's cash flow — Buffett, Lynch, Marks +4 more

    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    FCF Positive and Growing$-4.6M
    ✗LynchPositive and growing
    Operating Cash Flow$5.4M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=8.89%, ROA=-41.95%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)3.6x
    ✓Dreman< 8x
    P/E or FCF YieldFCF Yield=20.8%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive1/6 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-23.7%
    ✗Ackman>= 4%
    Price / FCF per Share3.6x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency1/6 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-4.6M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-17.95%; #3477/4519 (top 76.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Debt & Leverage50% pass✓ 8✗ 7▾

    6 of 12 pass — Graham, Buffett, Lynch +3 more object

    Debt Levels0.35
    ✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.56, IC: N/A
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.35
    ✗Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.74
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.35
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Interest Coverage & Debt/EBITDA
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.35
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.3528; #2142/4210 (top 50.9%)
    ✗AsnessTop 30% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Automobiles and Trucks
SIC Sector: Transportation Equipment
Size: Micro Cap($25.7M)
Revenue: $46.0M-17.8% YoY
Net Income: $25.3M+49.5% YoY

Financial Snapshot

Operating Margin-71.9%
Return on Equity-108.7%
Debt / Equity0.56
Current Ratio2.11
EPS (Diluted)$-2.71

Similar Companies

TSLATesla, Inc.
$1.54T
PCARPACCAR INC
$56.2B
FFORD MOTOR CO
$47.6B
HMCHONDA MOTOR CO LTD
$44.5B

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, operating cash flow, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-03-30
FY 2024
Sources
  • 10-K · 2025-03-31
FY 2023
Sources
  • 10-K · 2024-03-29
FY 2022
Sources
  • 10-K · 2023-03-31
FY 2021
Sources
  • 10-K · 2022-03-30
Market Cap$25.7Mcurrent------$30.3Mest.$25.0Mest.$48.6Mest.$4.8Best.$11.3Best.
Revenue$26.7M↓49%$5.5M↓66%$4.7M↓74%$11.2M↑91%$46.0M↓18%$56.0M↑26%$44.5M↑22%$36.4M↑621%$5.0M
Operating Income-$29.8M↑21%-$7.5M↓7%-$7.9M↓12%-$4.7M↑50%-$33.1M↑28%-$45.9M↑29%-$65.0M↑42%-$111.3M↓109%-$53.2M
Net Income-$29.2M↑15%-$7.6M↓458%-$6.9M↑8%-$5.0M↑51%-$25.3M↑50%-$50.2M↑34%-$75.8M↓3%-$73.3M↓413%$23.4M
EPS (Diluted)--$-0.52↓336%$-0.55↑40%$-0.43↑66%$-2.71↑59%$-6.69↑49%$-13.11↓2880%$-0.44↓300%$0.22
Gross Margin11.7%↑271%15.3%12.1%↑37%38.6%↑87%5.9%↓16%7.1%↑345%-2.9%↑96%-82.6%↓76%-46.8%
Operating Margin-111.6%↓54%-134.5%↓217%-167.7%↓335%-41.7%↑74%-71.9%↑12%-82.0%↑44%-145.9%↑52%-306.1%↑71%-1053.0%
ROE-145.4%↓31%———-108.7%↑27%-149.2%↑11%-167.8%↓156%-65.4%↓588%13.4%
Total Debt$7.1M↓55%$7.1M↓55%$8.7M↓48%$10.3M↑1316%$13.0M↑912%$1.3M↓94%$20.9M↓5%$21.9M$0
Shareholders' Equity$20.1M↓35%$20.1M↓35%$22.9M↑25%$19.8M↓20%$23.3M↓31%$33.6M↓26%$45.2M↓60%$112.1M↓36%$174.4M
Current Ratio1.74↓28%1.74↓28%2.00↓10%1.89↑17%2.11↑20%1.76↓52%3.66↑3%3.57↓66%10.38
Debt / Equity0.35↓30%0.35↓30%0.38↓58%0.52↑1675%0.56↑1361%0.04↓92%0.46↑137%0.200.00
Operating Cash Flow-$4.4M↓170%-$2.5M↓181%-$2.7M↓158%-$1.6M↑67%$5.4M↑111%-$48.8M↓24%-$39.3M↑69%-$128.0M↓44%-$88.9M
Free Cash Flow-$4.6M↓174%-$2.7M↓188%-$2.7M↓158%-$1.6M↑66%$5.4M↑111%-$49.1M↓21%-$40.7M↑71%-$142.1M↓51%-$93.8M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Automobiles and Trucks

XOS vs Peers — Financial Grading

Revenue$46.0MBottom 25%
Net Income$25.3MBottom 25%
ROE-108.7%Bottom 25%
D/E0.56Median
Op. Margin-71.9%Bottom 25%
Curr. Ratio2.11Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
Tesla, Inc.TSLA$1.54T$390.22$94.8B$3.8B4.6%0.024.6%2.162/95/92/70/3F-Score 53/11
PACCAR INCPCAR$56.2B$106.66$28.4B$2.4B12.3%0.00——3/93/92/70/3F-Score 44/11
FORD MOTOR COF$47.6B$11.91$187.3B$8.2B-22.7%—-4.9%1.072/90/91/70/3F-Score 43/11
HONDA MOTOR CO LTDHMC$44.5B$34.30$145.0B$5.6B6.8%0.715.6%1.361/92/91/70/3F-Score 43/11
MAGNA INTERNATIONAL INCMGA$16.0B$61.82$42.0B$829.0M6.6%0.38—1.253/92/92/70/3F-Score 63/11
BORGWARNER INCBWA$10.2B$50.89$14.3B$277.0M5.1%0.723.7%2.071/92/90/70/3F-Score 63/11
OSHKOSH CORPOSK$8.6B$141.78$10.4B$647.0M14.3%0.249.0%1.942/95/94/70/3F-Score 53/11
Aptiv PLCAPTV$7.8B$38.75$20.4B$165.0M1.8%0.825.8%1.744/90/90/73/3F-Score 85/11